Dr. Feng Zhang and other researchers from the Broad Institute have developed a new tool to complement CRISPR technology. SHERLOCK (specific high-sensitivity enzymatic reporter unlocking) is a CRISPR enzyme that can be used to detect as little as a single molecule of target RNA or DNA. It has vast potential in molecular diagnostics.

Previous articleEnsuring Research Integrity
Next articleUniQure Says It Will Not Pursue EC Marketing Renewal for Glybera Gene Therapy